You are currently viewing (Compilation of February Literature) Multi Science Products Cited in Top Journal NATURE CELL BIOLOGY

    (Compilation of February Literature) Multi Science Products Cited in Top Journal NATURE CELL BIOLOGY

    As of February 2024, a total of 9161 SCI papers citing Lianke/MultiSciences products have been indexed across the entire network! In February alone, 174 papers were included, citing 351 products, with a total IF value of 1267.6 and the highest IF reaching 21.3! There are 38 papers with an IF value of 10 or above.

    Cumulative Total Citations of SCI Papers Over the Years
    (As of February 2024)

    This article extracts 10 papers with an impact factor of over 15, covering various product categories such as ELISA, flow cytometry, and others. It showcases the latest research achievements in different fields, aiming to help readers broaden their research perspectives and enrich their methodologies.

    High-score Literature Compilation

    No.1


    Title:ECSIT facilitates memory CD8+ T cell development by mediating fumarate synthesis during viral infection and tumorigenesis
    Journal:NATURE CELL BIOLOGY
    IF:21.3
    Publication date:2024-02-07
    Application products:
    CS0001 Phorbol 12-Myristate 13-Acetate;
    CS0002 ionomycin

    No.2


    Title:Mesoporous Ternary Nanozymes with Anti-Senescence and Anti-Inflammation Activities for Atherosclerosis Management
    Journal:ADVANCED FUNCTIONAL MATERIALS
    IF:19
    Publication date:2024-02-08
    Application products:

    No.3


    Title:Antioxidant Nanozyme-Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction
    Journal:ADVANCED FUNCTIONAL MATERIALS
    IF:19
    Publication date:2024-02-19
    Affiliations:
    Zhejiang Chinese Medical University
    Zhejiang University School of Medicine
    Cancer Center of Zhejiang University
    The University of Hong Kong
    Chongqing International Institute for Immunology
    Application products:

    No.4


    Title:Biomimetic bacteria-derived nanoclusters enhance ferroptosis cancer immunotherapy through synergistic CRISPR-photothermo modulation
    Journal:Nano Today
    IF:17.4
    Publication date:2024-02-29
    Application products:

    No.5


    Title:
    Self-generated double-stranded RNA for enhancing tumor immunotherapy and metastasis inhibition
    Journal:Nano Today
    IF:17.4
    Publication date:2024-02-01
    Application products:

    No.6


    Title:Biologically Self-Assembled Tumor Cell-Derived Cancer Nanovaccines as an All-in-One Platform for Cancer Immunotherapy
    Journal:ACS Nano
    IF:17.1
    Publication date:2024-02-15
    Application products:

    No.7


    Title:AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation
    Journal: Nature Communications
    IF:16.6
    Publication date:2024-02-06
    Application products:

    No.8


    Title:Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway
    Journal: Nature Communications
    IF:16.6
    Publication date:2024-02-13
    Application products:

    No.9


    Title:Multifunctionalized and Dual-Crosslinked Hydrogel Promotes Inflammation Resolution and Bone Regeneration via NLRP3 Inhibition in Periodontitis
    Journal: Small Structures
    IF:15.9
    Publication date:2024-02-05
    Application products:

    No.10


    Title:Photothermal Microneedle Hydrogel Patch for Refractory Soft Tissue Injuries through Thermosensitized Anti-Inflammaging Modulation
    Journal:Small Structures
    IF:15.9
    Publication date:2024-02-22
    Application products:

    About Multi Sciences

    Multi Sciences was established in 2002. It is a high-tech enterprise engaged in biology and immunology-related diagnostic reagents R&D and production, including ELISA reagents, flow cytometry reagents, IVD products and etc.
    The production system is certified with ISO9001 international quality management system, the research and development system is certified with ISO13485 international quality management system.
    By the end of 2023, a total of 8820 SCI research papers cited Multi Sciences products, including top journals such as Science, Nature, and Cell, with the highest Impact Factor (IF) 68.164.
    Our products are sold in many countries around the world and are highly praised by research and corporate customers.